GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enlitic Inc (ASX:ENL) » Definitions » Investments And Advances

Enlitic (ASX:ENL) Investments And Advances : A$0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Enlitic Investments And Advances?

Enlitic's Investments And Advances for the quarter that ended in . 20 was A$0.00 Mil.


Enlitic Investments And Advances Historical Data

The historical data trend for Enlitic's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlitic Investments And Advances Chart

Enlitic Annual Data
Trend Dec23
Investments And Advances
-

Enlitic Quarterly Data
Dec23
Investments And Advances -

Enlitic Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Enlitic (ASX:ENL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3420 East Harmony Road, Suite 125, Fort Collins, CO, USA, 80528
Enlitic Inc is focused on artificial intelligence that enables effective administration, processing, and sharing of medical imaging data throughout the healthcare enterprise. It is also focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Enlitic provides a solid plan that addresses data inconsistencies and risk associated with moving studies containing PHI and is focused on using AI for the medical imaging layer of a real-world evidence (RWE), providing healthcare organizations with a stepwise approach to operationalizing their AI.

Enlitic (ASX:ENL) Headlines

No Headlines